Back

The effects of surgical and transcatheter aortic valve replacement for aortic stenosis on regression and progression of mitral regurgitation -a propensity score matched analysis

31 August 2025 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (3) - Treatment of aortic stenosis and TAVI Aortic Valve Intervention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Shirit Kazum

Rabin Medical Centre, Petah Tikva (Israel)

9 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor C. Olmos (Madrid, ES)
Abstract Slides
Presentation thumbnail
Professor E. Messas (Paris, FR)
Abstract
Presentation thumbnail
Mr A. Rocha De Almeida (Evora, PT)
Abstract Video
Presentation thumbnail
Mr J. Castro Martin (San Cristobal De La Laguna, ES)
Abstract Video

Access the full session

Session thumbnail
New perspectives in cardiology (3) - Treatment of aortic stenosis and TAVI

The Event

Event poster

ESC Congress 2025

31 August 2025 12:30 CET
You may be interested in
thumbnail
Congress Presentation
Improvement of mitral regurgitation following transcatheter aortic valve implantation: outcomes and predictors in a retrospective cohort study
thumbnail
Congress Presentation
Mitral regurgitation in TAVR patients: identifying risk factors for long-term persistence
thumbnail
Congress Presentation
Post-procedural in-hospital, short and long-term outcomes of transcatheter (percutaneous) versus surgical approach for management of patients with non-rheumatic mitral valve stenosis.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources